Market Executive Summary
The global Anticancer Drugs market was valued at US$ 190,012 million in 2023 and is anticipated to reach US$ 391,003 million by 2030, witnessing a CAGR of 11.26% during the forecast period 2024-2030.
North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the forecast period of 2024 through 2030.
Asia-Pacific market for Anticancer Drugs is estimated to increase from $ 39,518 million in 2023 to reach $ 89,042 million by 2030, at a CAGR of 12.38% during the forecast period of 2024 through 2030.
The global key manufacturers of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Eli Lilly, etc. In 2023, the global top five players had a share approximately 55.06% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.
The Anticancer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Global Anticancer Drugs Companies Covered
AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Global Anticancer Drugs Market, Segment by Type
Chemotherapy
Targeted Therapy
Cancer Immunotherapy
Other
Global Anticancer Drugs Market, Segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticancer Drugs manufacturers competitive landscape revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Revenue of Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Anticancer Drugs Market Overview 1
1.1 Product Definition 1
1.2 Anticancer Drugs by Type 1
1.2.1 Global Anticancer Drugs Market Value Comparison by Type (2024-2030) 2
1.2.2 Chemotherapy 4
1.2.3 Targeted Therapy 5
1.2.4 Cancer Immunotherapy 6
1.3 Anticancer Drugs by Application 8
1.3.1 Global Anticancer Drugs Market Value by Application (2024-2030) 8
1.3.2 Lung Cancer 11
1.3.3 Breast Cancer 11
1.3.4 Prostate Cancer 12
1.3.5 Blood-related Cancer 13
1.4 Global Anticancer Drugs Market Size Estimates and Forecasts 14
1.5 Assumptions and Limitations 16
2 Anticancer Drugs Market Competition by Manufacturers 18
2.1 Global Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024) 18
2.2 Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024 20
2.3 Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters 21
2.4 Global Key Manufacturers of Anticancer Drugs, Product Type 22
2.5 Global Key Manufacturers of Anticancer Drugs, Founded Date 23
2.6 Global Anticancer Drugs Market Competitive Situation and Trends 24
2.6.1 Global Anticancer Drugs Market Concentration Rate 24
2.6.2 The Global 5 and 10 Largest Anticancer Drugs Players Market Share by Revenue 25
2.6.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 26
2.7 Manufacturers Mergers & Acquisitions, Expansion Plans 27
3 Global Anticancer Drugs Market Scenario by Region 30
3.1 Global Anticancer Drugs Market Size by Region: 2019 Versus 2023 Versus 2030 30
3.2 Global Anticancer Drugs Revenue by Region: 2019-2030 31
3.2.1 Global Anticancer Drugs Revenue by Region: 2019-2024 31
3.2.2 Global Anticancer Drugs Revenue by Region: 2025-2030 32
3.3 North America Anticancer Drugs Market Facts & Figures by Country 33
3.3.1 North America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030 33
3.3.2 North America Anticancer Drugs Revenue by Country (2019-2030) 33
3.3.3 U.S. 34
3.3.4 Canada 35
3.3.5 Mexico 35
3.4 Europe Anticancer Drugs Market Facts & Figures by Country 36
3.4.1 Europe Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030 36
3.4.2 Europe Anticancer Drugs Revenue by Country (2019-2030) 36
3.4.3 Germany 38
3.4.4 France 38
3.4.5 U.K. 39
3.4.6 Italy 39
3.4.7 Russia 40
3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region 40
3.5.1 Asia Pacific Anticancer Drugs Market Size by Region: 2019 VS 2023 VS 2030 40
3.5.2 Asia Pacific Anticancer Drugs Revenue by Region (2019-2030) 41
3.5.3 China 42
3.5.4 Japan 43
3.5.5 South Korea 43
3.5.6 India 44
3.5.7 Australia 44
3.5.8 Southeast Asia 45
3.6 South America Anticancer Drugs Market Facts & Figures by Country 45
3.6.1 South America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030 45
3.6.2 South America Anticancer Drugs Revenue by Country 46
3.6.3 Brazil 46
3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country 47
3.7.1 Middle East and Africa Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030 47
3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country 47
3.7.3 Middle East 48
3.7.4 Africa 49
4 Segment by Type 50
4.1 Global Anticancer Drugs Revenue by Type (2019-2024) 50
4.2 Global Anticancer Drugs Revenue by Type (2025-2030) 50
4.3 Global Anticancer Drugs Revenue Market Share by Type (2019-2030) 50
5 Segment by Application 52
5.1 Global Anticancer Drugs Revenue by Application (2019-2024) 52
5.2 Global Anticancer Drugs Revenue by Application (2025-2030) 52
5.3 Global Anticancer Drugs Revenue Market Share by Application (2019-2030) 52
6 Key Companies Profiled 54
6.1 Abbvie 54
6.1.1 Abbvie Details 54
6.1.2 Abbvie Major Business 54
6.1.3 Abbvie Anticancer Drugs Product and Solutions 55
6.1.4 Abbvie Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 56
6.1.5 Abbvie Recent Developments and Future Plans 56
6.2 Johnson & Johnson 57
6.2.1 Johnson & Johnson Details 57
6.2.2 Johnson & Johnson Major Business 57
6.2.3 Johnson & Johnson Anticancer Drugs Product and Solutions 58
6.2.4 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 61
6.2.5 Johnson & Johnson Recent Developments and Future Plans 61
6.3 Novartis 61
6.3.1 Novartis Details 61
6.3.2 Novartis Major Business 62
6.3.3 Novartis Anticancer Drugs Product and Solutions 63
6.3.4 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 65
6.3.5 Novartis Recent Developments and Future Plans 65
6.4 Gilead Sciences 67
6.4.1 Gilead Sciences Details 67
6.4.2 Gilead Sciences Major Business 67
6.4.3 Gilead Sciences Anticancer Drugs Product and Solutions 68
6.4.4 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 70
6.4.5 Gilead Sciences Recent Developments and Future Plans 70
6.5 Roche 71
6.5.1 Roche Details 71
6.5.2 Roche Major Business 71
6.5.3 Roche Anticancer Drugs Product and Solutions 72
6.5.4 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 76
6.5.5 Roche Recent Developments and Future Plans 76
6.6 Bristol-Myers Squibb 78
6.6.1 Bristol-Myers Squibb Details 78
6.6.2 Bristol-Myers Squibb Major Business 78
6.6.3 Bristol-Myers Squibb Anticancer Drugs Product and Solutions 79
6.6.4 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 81
6.6.5 Bristol-Myers Squibb Recent Developments and Future Plans 81
6.7 Amgen 83
6.7.1 Amgen Details 83
6.7.2 Amgen Major Business 83
6.7.3 Amgen Anticancer Drugs Product and Solutions 84
6.7.4 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 85
6.7.5 Amgen Recent Developments and Future Plans 86
6.8 AstraZeneca 88
6.8.1 AstraZeneca Details 88
6.8.2 AstraZeneca Major Business 88
6.8.3 AstraZeneca Anticancer Drugs Product and Solutions 89
6.8.4 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 91
6.8.5 AstraZeneca Recent Developments and Future Plans 91
6.9 Merck & Co 94
6.9.1 Merck & Co Details 94
6.9.2 Merck & Co Major Business 94
6.9.3 Merck & Co Anticancer Drugs Product and Solutions 95
6.9.4 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 96
6.9.5 Merck & Co Recent Developments and Future Plans 97
6.10 Takeda 98
6.10.1 Takeda Details 98
6.10.2 Takeda Major Business 98
6.10.3 Takeda Anticancer Drugs Product and Solutions 99
6.10.4 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 100
6.10.5 Takeda Recent Developments and Future Plans 100
6.11 Merck KGaA 103
6.11.1 Merck KGaA Details 103
6.11.2 Merck KGaA Major Business 103
6.11.3 Merck KGaA Anticancer Drugs Product and Solutions 104
6.11.4 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 105
6.11.5 Merck KGaA Recent Developments and Future Plans 106
6.12 Seagen 107
6.12.1 Seagen Details 107
6.12.2 Seagen Major Business 107
6.12.3 Seagen Anticancer Drugs Product and Solutions 108
6.12.4 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 109
6.12.5 Seagen Recent Developments and Future Plans 109
6.13 Eli Lilly 111
6.13.1 Eli Lilly Details 111
6.13.2 Eli Lilly Major Business 111
6.13.3 Eli Lilly Anticancer Drugs Product and Solutions 112
6.13.4 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 113
6.14 Ono Pharmaceutical 114
6.14.1 Ono Pharmaceutical Details 114
6.14.2 Ono Pharmaceutical Major Business 114
6.14.3 Ono Pharmaceutical Anticancer Drugs Product and Solutions 115
6.14.4 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 116
6.14.5 Ono Pharmaceutical Recent Developments and Future Plans 116
6.15 Pfizer 118
6.15.1 Pfizer Details 118
6.15.2 Pfizer Major Business 118
6.15.3 Pfizer Anticancer Drugs Product and Solutions 119
6.15.4 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 121
6.15.5 Pfizer Recent Developments and Future Plans 121
6.16 GSK 123
6.16.1 GSK Details 123
6.16.2 GSK Major Business 123
6.16.3 GSK Anticancer Drugs Product and Solutions 124
6.16.4 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 125
6.16.5 GSK Recent Developments and Future Plans 125
6.17 Exelixis 127
6.17.1 Exelixis Details 127
6.17.2 Exelixis Major Business 127
6.17.3 Exelixis Anticancer Drugs Product and Solutions 128
6.17.4 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 129
6.17.5 Exelixis Recent Developments and Future Plans 130
6.18 Regeneron 131
6.18.1 Regeneron Details 131
6.18.2 Regeneron Major Business 131
6.18.3 Regeneron Anticancer Drugs Product and Solutions 132
6.18.4 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 132
6.19 Innovent 134
6.19.1 Innovent Details 134
6.19.2 Innovent Major Business 134
6.19.3 Innovent Anticancer Drugs Product and Solutions 135
6.19.4 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 136
6.20 Hengrui Medicine 137
6.20.1 Hengrui Medicine Details 137
6.20.2 Hengrui Medicine Major Business 137
6.20.3 Hengrui Medicine Anticancer Drugs Product and Solutions 138
6.20.4 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 138
7 Industry Chain and Sales Channels Analysis 139
7.1 Anticancer Drugs Industry Chain Analysis 139
7.2 Anticancer Drugs Key Raw Materials 140
7.2.1 Key Raw Materials 140
7.2.2 Raw Materials Key Suppliers 141
7.3 Anticancer Drugs Production Mode & Process 141
7.4 Anticancer Drugs Sales and Marketing 142
7.4.1 Anticancer Drugs Sales Channels 143
7.4.2 Anticancer Drugs Distributors 144
7.5 Anticancer Drugs Customers 146
8 Anticancer Drugs Market Dynamics 148
8.1 Anticancer Drugs Industry Trends 148
8.2 Anticancer Drugs Market Drivers 149
8.3 Anticancer Drugs Market Challenges 150
8.4 Anticancer Drugs Market Restraints 151
9 Research Findings and Conclusion 152
10 Methodology and Data Source 154
10.1 Methodology/Research Approach 154
10.1.1 Research Programs/Design 154
10.1.2 Market Size Estimation 155
10.1.3 Market Breakdown and Data Triangulation 156
10.2 Data Source 157
10.2.1 Secondary Sources 157
10.2.2 Primary Sources 158
10.3 Author List 160
10.4 Disclaimer 161
List of Figures
Table 1. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million) 2
Table 2. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million) 8
Table 3. Global Anticancer Drugs Revenue (US$ Million) by Manufacturers (2019-2024) 18
Table 4. Global Anticancer Drugs Revenue Share by Manufacturers (2019-2024) 19
Table 5. Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024 20
Table 6. Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters 21
Table 7. Global Key Manufacturers of Anticancer Drugs, Product Type 22
Table 8. Global Key Manufacturers of Anticancer Drugs, Founded Date 23
Table 9. Global Manufacturers Market Concentration Ratio (CR5 and HHI) 24
Table 10. Global Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2023) 26
Table 11. Manufacturers Mergers & Acquisitions, Expansion Plans 27
Table 12. Global Anticancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 30
Table 13. Global Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million) 31
Table 14. Global Anticancer Drugs Revenue Market Share by Region (2019-2024) 32
Table 15. Global Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million) 32
Table 16. Global Anticancer Drugs Revenue Market Share by Region (2025-2030) 32
Table 17. North America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 33
Table 18. North America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million) 33
Table 19. North America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million) 33
Table 20. Europe Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 36
Table 21. Europe Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million) 36
Table 22. Europe Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million) 36
Table 23. Asia Pacific Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million) 40
Table 24. Asia Pacific Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million) 41
Table 25. Asia Pacific Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million) 41
Table 26. South America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 45
Table 27. South America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million) 46
Table 28. South America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million) 46
Table 29. Middle East and Africa Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 47
Table 30. Middle East and Africa Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million) 47
Table 31. Middle East and Africa Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million) 47
Table 32. Global Anticancer Drugs Revenue (US$ Million) by Type (2019-2024) 50
Table 33. Global Anticancer Drugs Revenue (US$ Million) by Type (2025-2030) 50
Table 34. Global Anticancer Drugs Revenue Market Share by Type (2019-2024) 50
Table 35. Global Anticancer Drugs Revenue Market Share by Type (2025-2030) 51
Table 36. Global Anticancer Drugs Revenue (US$ Million) by Application (2019-2024) 52
Table 37. Global Anticancer Drugs Revenue (US$ Million) by Application (2025-2030) 52
Table 38. Global Anticancer Drugs Revenue Market Share by Application (2019-2024) 52
Table 39. Global Anticancer Drugs Revenue Market Share by Application (2025-2030) 53
Table 40. Abbvie Company Information, Head Office, and Major Competitors 54
Table 41. Abbvie Major Business 54
Table 42. Abbvie Anticancer Drugs Product and Solutions 55
Table 43. Abbvie Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 56
Table 44. Abbvie Recent Developments and Future Plans 56
Table 45. Johnson & Johnson Company Information, Head Office, and Major Competitors 57
Table 46. Johnson & Johnson Major Business 57
Table 47. Johnson & Johnson Anticancer Drugs Product and Solutions 58
Table 48. Johnson & Johnson Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 61
Table 49. Johnson & Johnson Recent Developments and Future Plans 61
Table 50. Novartis Company Information, Head Office, and Major Competitors 61
Table 51. Novartis Major Business 62
Table 52. Novartis Anticancer Drugs Product and Solutions 63
Table 53. Novartis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 65
Table 54. Novartis Recent Developments and Future Plans 65
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors 67
Table 56. Gilead Sciences Major Business 67
Table 57. Gilead Sciences Anticancer Drugs Product and Solutions 68
Table 58. Gilead Sciences Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 70
Table 59. Gilead Sciences Recent Developments and Future Plans 70
Table 60. Roche Company Information, Head Office, and Major Competitors 71
Table 61. Roche Major Business 71
Table 62. Roche Anticancer Drugs Product and Solutions 72
Table 63. Roche Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 76
Table 64. Roche Recent Developments and Future Plans 76
Table 65. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors 78
Table 66. Bristol-Myers Squibb Major Business 78
Table 67. Bristol-Myers Squibb Anticancer Drugs Product and Solutions 79
Table 68. Bristol-Myers Squibb Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 81
Table 69. Bristol-Myers Squibb Recent Developments and Future Plans 81
Table 70. Amgen Company Information, Head Office, and Major Competitors 83
Table 71. Amgen Major Business 83
Table 72. Amgen Anticancer Drugs Product and Solutions 84
Table 73. Amgen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 85
Table 74. Amgen Recent Developments and Future Plans 86
Table 75. AstraZeneca Company Information, Head Office, and Major Competitors 88
Table 76. AstraZeneca Major Business 88
Table 77. AstraZeneca Anticancer Drugs Product and Solutions 89
Table 78. AstraZeneca Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 91
Table 79. AstraZeneca Recent Developments and Future Plans 91
Table 80. Merck & Co Company Information, Head Office, and Major Competitors 94
Table 81. Merck & Co Major Business 94
Table 82. Merck & Co Anticancer Drugs Product and Solutions 95
Table 83. Merck & Co Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 96
Table 84. Takeda Company Information, Head Office, and Major Competitors 98
Table 85. Takeda Major Business 98
Table 86. Takeda Anticancer Drugs Product and Solutions 99
Table 87. Takeda Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 100
Table 88. Takeda Recent Developments and Future Plans 100
Table 89. Merck KGaA Company Information, Head Office, and Major Competitors 103
Table 90. Merck KGaA Major Business 103
Table 91. Merck KGaA Anticancer Drugs Product and Solutions 104
Table 92. Merck KGaA Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 105
Table 93. Merck KGaA Recent Developments and Future Plans 106
Table 94. Seagen Company Information, Head Office, and Major Competitors 107
Table 95. Seagen Major Business 107
Table 96. Seagen Anticancer Drugs Product and Solutions 108
Table 97. Seagen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 109
Table 98. Seagen Recent Developments and Future Plans 109
Table 99. Eli Lilly Company Information, Head Office, and Major Competitors 111
Table 100. Eli Lilly Major Business 111
Table 101. Eli Lilly Anticancer Drugs Product and Solutions 112
Table 102. Eli Lilly Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 113
Table 103. Ono Pharmaceutical Company Information, Head Office, and Major Competitors 114
Table 104. Ono Pharmaceutical Major Business 114
Table 105. Ono Pharmaceutical Anticancer Drugs Product and Solutions 115
Table 106. Ono Pharmaceutical Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 116
Table 107. Ono Pharmaceutical Recent Developments and Future Plans 116
Table 108. Pfizer Company Information, Head Office, and Major Competitors 118
Table 109. Pfizer Major Business 118
Table 110. Pfizer Anticancer Drugs Product and Solutions 119
Table 111. Pfizer Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 121
Table 112. Pfizer Recent Developments and Future Plans 121
Table 113. GSK Company Information, Head Office, and Major Competitors 123
Table 114. GSK Major Business 123
Table 115. GSK Anticancer Drugs Product and Solutions 124
Table 116. GSK Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 125
Table 117. GSK Recent Developments and Future Plans 125
Table 118. Exelixis Company Information, Head Office, and Major Competitors 127
Table 119. Exelixis Major Business 127
Table 120. Exelixis Anticancer Drugs Product and Solutions 128
Table 121. Exelixis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 129
Table 122. Exelixis Recent Developments and Future Plans 130
Table 123. Regeneron Company Information, Head Office, and Major Competitors 131
Table 124. Regeneron Major Business 131
Table 125. Regeneron Anticancer Drugs Product and Solutions 132
Table 126. Regeneron Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 132
Table 127. Innovent Company Information, Head Office, and Major Competitors 134
Table 128. Innovent Major Business 134
Table 129. Innovent Anticancer Drugs Product and Solutions 135
Table 130. Innovent Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 136
Table 131. Hengrui Medicine Company Information, Head Office, and Major Competitors 137
Table 132. Hengrui Medicine Major Business 137
Table 133. Hengrui Medicine Anticancer Drugs Product and Solutions 138
Table 134. Hengrui Medicine Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024) 138
Table 135. Key Raw Materials Lists 140
Table 136. Raw Materials Key Suppliers Lists 141
Table 137. Anticancer Drugs Distributors List 144
Table 138. Anticancer Drugs Customers List 146
Table 139. Anticancer Drugs Market Trends 148
Table 140. Anticancer Drugs Market Drivers 149
Table 141. Anticancer Drugs Market Challenges 150
Table 142. Anticancer Drugs Market Restraints 151
Table 143. Research Programs/Design for This Report 154
Table 144. Key Data Information from Secondary Sources 158
Table 145. Key Data Information from Primary Sources 159
Table 146. Authors List of This Report 160
List of Figures
Figure 1. Product Picture of Anticancer Drugs 1
Figure 2. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million) 2
Figure 3. Global Anticancer Drugs Market Share by Type: 2023 3
Figure 4. Global Anticancer Drugs Market Share by Type: 2030 3
Figure 5. Chemotherapy Product Picture 4
Figure 6. Targeted Therapy Product Picture 6
Figure 7. Cancer Immunotherapy Product Picture 7
Figure 8. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million) 9
Figure 9. Global Anticancer Drugs Market Share by Application: 2023 10
Figure 10. Global Anticancer Drugs Market Share by Application: 2030 10
Figure 11. Lung Cancer 11
Figure 12. Breast Cancer 12
Figure 13. Prostate Cancer 13
Figure 14. Blood-related Cancer 14
Figure 15. Global Anticancer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030 15
Figure 16. Global Anticancer Drugs Market Size (2019-2030) & (US$ Million) 15
Figure 17. Anticancer Drugs Report Years Considered 17
Figure 18. Global Anticancer Drugs Revenue Share by Manufacturers in 2023 20
Figure 19. Global 5 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023 25
Figure 20. Global 10 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023 26
Figure 21. Global Anticancer Drugs Market Size by Region (US$ Million): 2019-2030 31
Figure 22. North America Anticancer Drugs Revenue Market Share by Country (2019-2030) 34
Figure 23. U.S. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 34
Figure 24. Canada Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 35
Figure 25. Mexico Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 35
Figure 26. Europe Anticancer Drugs Revenue Market Share by Country (2019-2030) 37
Figure 27. Germany Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 38
Figure 28. France Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 38
Figure 29. U.K. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 39
Figure 30. Italy Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 39
Figure 31. Russia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 40
Figure 32. Asia Pacific Anticancer Drugs Revenue Market Share by Region (2019-2030) 42
Figure 33. China Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 42
Figure 34. Japan Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 43
Figure 35. South Korea Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 43
Figure 36. India Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 44
Figure 37. Australia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 44
Figure 38. Southeast Asia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 45
Figure 39. Brazil Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 46
Figure 40. Middle East and Africa Anticancer Drugs Revenue Market Share by Country (2019-2030) 48
Figure 41. Middle East Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 48
Figure 42. Africa Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million) 49
Figure 43. Global Revenue Market Share of Anticancer Drugs by Type (2019-2030) 51
Figure 44. Global Revenue Market Share of Anticancer Drugs by Application (2019-2030) 53
Figure 45. Merck & Co Recent Developments and Future Plans 97
Figure 46. Anticancer Drugs Value Chain 140
Figure 47. Anticancer Drugs Production Process (Capsule) 141
Figure 48. Anticancer Drugs Production Process (Injection) 142
Figure 49. Anticancer Drugs Production Process (Tablet) 142
Figure 50. Channels of Distribution (Direct Vs Distribution) 143
Figure 51. Bottom-up and Top-down Approaches for This Report 156
Figure 52. Data Triangulation 157
Figure 53. Key Executives Interviewed 159
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
